StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 10/15/2013 -- StockRunway.com issues special report on – Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Amarin Corporation plc (ADR) (NASDAQ:AMRN), Antares Pharma Inc (NASDAQ:ATRS), MannKind Corporation (NASDAQ:MNKD)
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock is at $4.20, down -1.41 percent from its previous close of $4.26. The stock opened the session at $4.27 and touched its highest price point at $4.54. Stocks graphical chart shows a bearish trend during its last one month’s trading session. It remained negative with -79.98% during previous three months trade. Its recent trading volume was 34.04 million shares in comparison to its usual trading volume of 9.36 million shares. ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients.
Has ARIA Found The Bottom and Ready To Move Up? Find Out Here
Amarin Corporation plc (ADR) (NASDAQ:AMRN) stock is at $5.01, down -1.57 percent from its previous close of $5.09. Its today’s volume is 16.89 million shares in comparison to its usual trading volume of 6.84 million shares. The stock opened the session at $5.05 and touched its highest price point at $5.25.
AMRN quarterly performance remained red with the percentage of -10.54, while its year to date performance showed that the stock plunged overall -38.07%. Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases.
Has AMRN Found The Bottom And Ready To Gain Momentum? Find Out Here
Antares Pharma Inc (NASDAQ:ATRS) experienced a upsurge of 3.53% to a market valuation of $596.38M for previous trading session. After opening the day at $5.11 per share, volume surged to 12.57 million. During last one month it rose with the percentage of 7.08. Its year to date performance remained progressive with 42.12%. Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies, and topical gel-based medicines worldwide.
Will ATRS Continue To Move Higher? Find Out Here
MannKind Corporation (NASDAQ:MNKD) opened its shares at the price of $5.23 for the day, its closing price was $5.29 after gaining 3.41% for the day. The company traded with the total volume of 11.04 million shares while its average trading aptitude remained 4.92 million shares. The company has total of 301.77 million outstanding shares and its total market capitalization is $1.60 billion. MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States.
Why Should Investors Buy MNKD After The Recent Gain? Just Go Here and Find Out
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)